Morrison Foerster named among Law360’s Practice Groups of the Year in Capital Markets, Fintech and Life Sciences

Law360 has selected MoFo’s Capital Markets, Fintech, and Life Sciences practices as 2023 Practice Groups of the Year. Now in its 14th year, the Law360 awards honor the law firms behind major deals and litigation wins that resonated throughout the legal industry in the past year.

Morrison Foerster’s leading Capital Markets group advises issuers, underwriters, including the largest investment banks in the U.S., and others in a broad range of domestic and international private and public financings. The practice extends to all types of equity transactions and debt instruments and includes financings by U.S. and non-U.S. companies across markets worldwide. The team has been involved in some of the biggest landmark deals shaping the future of the tech industry. In 2023, MoFo notably represented Arm, the world’s leading semiconductor IP company, in its blockbuster $5.22 billion listing on Nasdaq, the largest IPO of 2023 globally. Arm’s planned listing drew enormous attention, garnering front-page headlines daily. The deal, the largest IPO since 2021, was seen as a bellwether for the IPO market given the challenging financial conditions. MoFo combines a deep understanding of capital markets law with unmatched SEC regulatory and public company governance expertise and ESG thought leadership.

MoFo’s multidisciplinary Fintech team represents a wide range of clients from global, regional, and community banks, to non-bank Fintechs, venture capital and private equity funds, merchants, start-ups and Big Tech. Our unique depth of experience and premier transactional, regulatory, litigation and enforcement capabilities across our international team enable us to offer creative, insightful and effective solutions for our clients across the global fintech market. The team has been involved in many of the deals that have shaped the fintech sector, and is sought after for its in-depth knowledge of the technology underpinning innovative digital first financial products and services, including as it relates to payments, lending, banking, digital assets, artificial intelligence and web3-based products and services. In addition to deal support, the MoFo Fintech team is well-known for its expertise in helping clients at every stage structure and launch novel digital-first products and services in regulated markets.

MoFo’s Life Sciences Group leads the legal field in representing groundbreaking innovators at the cutting-edge of the life sciences industry. Among the team’s clients are some of the leading names in the biotechnology, pharmaceutical, and healthcare industries, including nearly half of the top 20 pharmaceutical companies in the world, and some of the fastest growing companies at the intersection of life sciences and data analytics. With 100+ advanced scientific and engineering degrees, including 80+ Ph.D.s in life sciences and related engineering disciplines, the team has a deep understanding of the business of the life science industry and excels at bridging the gap between law and science. MoFo’s leading position lies in the diversity of our industry practice and scientific experience, cutting across nearly every practice group, including corporate, intellectual property, FDA regulatory, privacy, transactions, licensing, and litigation. MoFo works with innovators at every phase of their growth cycle, from conception to commercialization and exit, vigilantly protecting and enforcing our client’s rights in a competitive market.